Abstract:Accumulating evidence suggests that spinal cord astrocytes play an important role in neuropathic pain sensitization by releasing astrocytic mediators (e.g. cytokines, chemokines and growth factors). However, it remains unclear how astrocytes control the release of astrocytic mediators and sustain late-phase neuropathic pain. Astrocytic connexin-43 (now known as GJ1) has been implicated in gap junction and hemichannel communication of cytosolic contents through the glial syncytia and to the extracellular space, respectively. Connexin-43 also plays an essential role in facilitating the development of neuropathic pain, yet the mechanism for this contribution remains unknown. In this study, we investigated whether nerve injury could upregulate connexin-43 to sustain late-phase neuropathic pain by releasing chemokine from spinal astrocytes. Chronic constriction injury elicited a persistent upregulation of connexin-43 in spinal astrocytes for >3 weeks. Spinal (intrathecal) injection of carbenoxolone (a non-selective hemichannel blocker) and selective connexin-43 blockers (connexin-43 mimetic peptides (43)Gap26 and (37,43)Gap27), as well as astroglial toxin but not microglial inhibitors, given 3 weeks after nerve injury, effectively reduced mechanical allodynia, a cardinal feature of late-phase neuropathic pain. In cultured astrocytes, TNF-α elicited marked release of the chemokine CXCL1, and the release was blocked by carbenoxolone, Gap26/Gap27, and connexin-43 small interfering RNA. TNF-α also increased connexin-43 expression and hemichannel activity, but not gap junction communication in astrocyte cultures prepared from cortices and spinal cords. Spinal injection of TNF-α-activated astrocytes was sufficient to induce persistent mechanical allodynia, and this allodynia was suppressed by CXCL1 neutralization, CXCL1 receptor (CXCR2) antagonist, and pretreatment of astrocytes with connexin-43 small interfering RNA. Furthermore, nerve injury persistently increased excitatory synaptic transmission (spontaneous excitatory postsynaptic currents) in spinal lamina IIo nociceptive synapses in the late phase, and this increase was suppressed by carbenoxolone and Gap27, and recapitulated by CXCL1. Together, our findings demonstrate a novel mechanism of astrocytic connexin-43 to enhance spinal cord synaptic transmission and maintain neuropathic pain in the late-phase via releasing chemokines.

Temporal changes of astrocyte activation and glutamate transporter-1 expression in the spinal cord after spinal nerve ligation-induced neuropathic pain.

Crosstalk Between Spinal Astrocytes and Neurons in Nerve Injury-Induced Neuropathic Pain

THE RELATIONSHIP BETWEEN THE SPINAL ASTROCYTIC ACTIVATION AND NEUROPATHIC PAIN BEHAVIOR FOLLOWING SPINAL NERVE LIGATION

Astrocytic Purinergic Signalling Contributes to the Development and Maintenance of Neuropathic Pain Via Modulation of Glutamate Release

Plasticity in expression of the glutamate transporters GLT-1 and GLAST in spinal dorsal horn glial cells following partial sciatic nerve ligation

Temporal Changes of Spinal Transcriptomic Profiles in Mice With Spinal Nerve Ligation.

Activation and Significance of Astrocytes in Spinal Cord of Spinal Nerve Selective Ligation Rats’ Mirror-Image Pain Model

Astrocytic c-Jun N-terminal kinase-histone deacetylase-2 cascade contributes to glutamate transporter-1 decrease and mechanical allodynia following peripheral nerve injury in rats

Role of astroglial glutamate-glutamine shuttle in the development of neuropathic pain in rats

Sequential alteration of microglia and astrocytes in the rat thalamus following spinal nerve ligation

Glial Activation in Spinal Cord in a Rat Model of Neuropathic Pain

Expression of LC3 and Beclin 1 in the Spinal Dorsal Horn Following Spinal Nerve Ligation-Induced Neuropathic Pain

A Model of Neuropathic Pain in Brachial Plexus Avulsion Injury and Associated Spinal Glial Cell Activation

Activation of Satellite Glial Cells in Lumbar Dorsal Root Ganglia Contributes to Neuropathic Pain after Spinal Nerve Ligation

Brain-derived Neurotrophic Factor–activated Astrocytes Produce Mechanical Allodynia in Neuropathic Pain

Connexin-43 Induces Chemokine Release from Spinal Cord Astrocytes to Maintain Late-Phase Neuropathic Pain in Mice

Effects of Glial Cell Line-Derived Neurotrophic Factor Intrathecal Injection on Spinal Dorsal Horn Glial Fibrillary Acidic Protein Expression in a Rat Model of Neuropathic Pain

Glial activation in the periaqueductal gray promotes descending facilitation of neuropathic pain through the p38 MAPK signaling pathway

Change in activity of NF-κB in astrocytes in spinal dorsal horn in a rat model of neuropathic pain

Astrocytic NDRG2 is Critical in the Maintenance of Neuropathic Pain

Changes in Long-Term Synaptic Plasticity in the Spinal Dorsal Horn of Neuropathic Pain Rats